Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Octreotide acetate (oral use)

EU orphan designation number: EU/3/13/1170   
Active ingredient: Octreotide acetate (oral use)
Indication: Treatment of acromegaly
Sponsor: Larode Ltd
Rhode Farm, Priory Lane, Selborne, Hampshire GU34 3BU, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/08/2013 Centralised Orphan - Designation EMA/OD/042/13 (2013)5270 of 05/08/2013
25/09/2014 Centralised Orphan - Change of address